Budesonide, gastro-resistant hard capsules with prolonged release properties, 3 mg, product-specific bioequivalence guidance

This document provides product-specific guidance on the demonstration of budesonide, gastro-resistant hard capsules with prolonged release properties, 3 mg.

Keywords: Bioequivalence, generics, budesonide

 

Current version

Budesonide, gastro-resistant hard capsules with prolonged release properties, 3 mg, product-specific bioequivalence guidance

AdoptedReference Number: EMA/CHMP/219393/2024Legal effective date: 01/09/2025

Document history

Budesonide, gastro-resistant hard capsules with prolonged release properties, 3 mg, product-specific bioequivalence guidance

Draft: consultation closedConsultation dates: 25/06/2024 to 30/09/2024Reference Number: EMA/CHMP/219393/2024Summary:

Comments should be provided using this EUSurvey form. For any technical issues, please contact the EUSurvey Support.